logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Antidepressant noncompliance as a factor in the discontinuation syndrome. Discussion.

    Article, Congrès - En anglais

    SSRI Discontinuation Events. Closed Symposium. Phoenix, Arizona (USA), 1996/12/17.

    Compliance is generally defined as the extent to which a patient adheres to a treatment regimen and, specifically, takes medication as prescribed.

    While little research is available about the number of patients who consistently skip antidepressant doses, the literature indicates that about 30% of patients discontinue treatment suddenly within the first month.

    Both missed doses and abrupt stoppage of treatment place a patient at risk for experiencing discontinuation symptoms.

    A variety of reasons ranging from forgetfulness to lack of knowledge about the importance of taking every dose may lead to nonadherence to an antidepressant regimen.

    By spending time on patient education, providing reasons why patients should take every antidepressant dose, discussing alternative treatments, and conveying empathy, support for, and understanding of the patient, physicians may be able to minimize noncompliance and consequently decrease the likelihood that a patient may experience discontinuation symptoms.

    Discontinuation of an antidepressant can cause a patient to be irritable, experience severe dizziness, or act emotionally ahsent, which may have a sustained adverse impact both on job performance and on family and social relationships.

    Mots-clés Pascal : Inhibiteur recapture, Sérotonine, Antidépresseur, Psychotrope, Arrêt traitement, Toxicité, Complication, Observance médicamenteuse, Observance thérapeutique, Education santé, Malade, Prévention, Homme

    Mots-clés Pascal anglais : Reuptake inhibitor, Serotonin, Antidepressant agent, Psychotropic, Withdrawal, Toxicity, Complication, Drug compliance, Treatment compliance, Health education, Patient, Prevention, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0435251

    Code Inist : 002B02U01. Création : 19/12/1997.